Cargando…
MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. Nat. Med. 2023, 29, 115–126
Autores principales: | Neuzil, Jiri, Rohlena, Jakub, Werner, Lukas, Bielcikova, Zuzana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526283/ https://www.ncbi.nlm.nih.gov/pubmed/37760446 http://dx.doi.org/10.3390/cancers15184476 |
Ejemplares similares
-
Repurposing of MitoTam: Novel Anti-Cancer Drug Candidate Exhibits Potent Activity against Major Protozoan and Fungal Pathogens
por: Arbon, Dominik, et al.
Publicado: (2022) -
Enriching plausible new hypothesis generation in PubMed
por: Baek, Seung Han, et al.
Publicado: (2017) -
Lipoxin-Induced Phenotypic Changes in CD115(+)LY6C(hi) Monocytes TAM Precursors Inhibits Tumor Development
por: de-Brito, Natália Mesquita, et al.
Publicado: (2019) -
MicroRNA-126 induces autophagy by altering cell metabolism in malignant mesothelioma
por: Tomasetti, Marco, et al.
Publicado: (2016) -
Memorandum: list of participants to letter of intent SPSC-I-126
por: Quercigh, Emanuele
Publicado: (1980)